Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate
Authors:
Open Access
- 6 April 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (6) , 1162-1164
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Interstitial pneumonitis during imatinib therapyBritish Journal of Haematology, 2004
- Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltrationLeukemia, 2004
- Imatinib Mesylate-Induced Interstitial PneumonitisMayo Clinic Proceedings, 2003
- Challenging Problems in Advanced MalignancyJournal of Clinical Oncology, 2003
- Hypersensitivity Pneumonitis Related to Imatinib MesylateJournal of Clinical Oncology, 2002
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Pulmonary Drug Toxicity: Radiologic and Pathologic ManifestationsRadioGraphics, 2000